The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)

<div>Schematic depiction of the four different kinds of vaccines, viz., nonreplicating viral vector vaccine, mRNA-based vaccine, inactivated virus vaccine, and protein subunit-based vaccine.</div>

BioMed Research International

fig5

Figure 5

Figure 5: The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) 

Figure 5 | The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) 